معرفی
Professor Rebecca Ritchie is a leading academic in Cardiac Pharmacology at Monash University, serving as Head of Drug Discovery Biology and Heart Failure Pharmacology. She specializes in translational research targeting heart failure progression, particularly in diabetes-associated cardiomyopathy. Her work bridges discovery, preclinical, and clinical research, with collaborations across multiple institutions including the Victorian Heart Institute and Baker Heart and Diabetes Institute.
Education: PhD in Cardiology (University of Adelaide, 1994), B.Sc. (Hons) in Clinical and Experimental Pharmacology (University of Adelaide, 1989).
Research Interests:
- Diabetes-associated heart failure
- Heart failure post-myocardial infarction
- Sex differences in cardiovascular outcomes
- Preclinical models of diabetic cardiomyopathy
Grants & Awards:
- NHMRC Australia Ideas Grant (2024–2027)
- ASCEPT Lecturer Award (2022)
- Fellow, International Society of Heart Research (2021)
- NHMRC Senior Research Fellowship (2014)
Advising & Grants:
- Lead Investigator on multiple NHMRC, MRFF, and industry grants
- Co-Director of Drug Discovery and Translation Flagship (Australian Cardiovascular Alliance)
- Guiding 23 research projects, including therapies targeting formyl peptide receptors and mitochondrial dysfunction
Labs/Teams: Heads the Heart Failure Pharmacology team and collaborates with global networks in cardiovascular research.
